Extending Tissue Plasminogen Activator Use to Community and Rural Stroke Patients | Zendy

José G. Merino | Zendy; Brian Silver | Zendy; Edward Wong | Zendy; Blaine T Foell | Zendy; Bart M. Demaerschalk | Zendy; Arturo Tamayo | Zendy; Fali Poncha | Zendy; Vladimir Hachinski | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Extending Tissue Plasminogen Activator Use to Community and Rural Stroke Patients

Author(s) -

José G. Merino,

Brian Silver,

Edward Wong,

Blaine T Foell,

Bart M. Demaerschalk,

Arturo Tamayo,

Fali Poncha,

Vladimir Hachinski

Publication year - 2002

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/hs0102.100481

Subject(s) - medicine , thrombolysis , tissue plasminogen activator , prospective cohort study , stroke (engine) , emergency department , tertiary care , limiting , acute stroke , fibrinolytic agent , emergency medicine , surgery , mechanical engineering , psychiatry , myocardial infarction , engineering

Guidelines for intravenous tissue plasminogen activator (tPA) use in stroke emphasize the importance of limiting its use to facilities with imaging capabilities and stroke expertise. This prospective case series set out to evaluate the safety of tPA use in patients referred from rural communities to a tertiary center.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research